MENU

BOLT Bolt Biotherapeutics Inc Forecast, Technical & Fundamental Analysis

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer... Show more

BOLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
BOLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BOLT is expected to report earnings to fall 18.33% to -351 cents per share on November 05

Bolt Biotherapeutics Inc BOLT Stock Earnings Reports
Q3'26
Est.
$-3.52
Q1'26
Missed
by $3.95
Q4'25
Missed
by $3.54
Q3'25
Missed
by $3.42
Q2'25
Missed
by $4.15
The last earnings report on May 12 showed earnings per share of -430 cents, missing the estimate of -36 cents. With 41.78K shares outstanding, the current market capitalization sits at 7.61M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
900 Chesapeake Drive
Phone
+1 650 665-9295
Employees
23
Web
https://www.boltbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMGL4.790.18
+3.79%
Basel Medical Group Ltd
VLRS6.520.05
+0.77%
CONTROLADORA VUELA COMPAniA DE AVIACIoN SAB DE CV
FE46.13-0.12
-0.26%
FirstEnergy Corp
LEGN18.64-0.55
-2.87%
Legend Biotech Corp
UP3.70-0.21
-5.37%
Wheels Up Experience

BOLT and Stocks

Correlation & Price change

A.I.dvisor tells us that BOLT and XENE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOLT and XENE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
+2.26%
XENE - BOLT
31%
Poorly correlated
-0.26%
ARRY - BOLT
30%
Poorly correlated
+1.54%
KRRO - BOLT
29%
Poorly correlated
+5.74%
NRXP - BOLT
29%
Poorly correlated
N/A
SPRO - BOLT
28%
Poorly correlated
+0.89%
More
Bolt Biotherapeutics (BOLT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com